Inducing labor improves maternal outcomes in mild hypertensive disease


Women with mild hypertensive disease who undergo induction of labor at 37 weeks or more have a lower risk of poor outcome.

Women experiencing mild hypertensive disease during pregnancy who undergo induction of labor at 37 weeks' gestation or beyond are at a 29% lower risk of a poor outcome, according to a study published online August 4 in the The Lancet.

Corine M. Koopmans, MD, of University Medical Centre in Groningen, Netherlands, and colleagues randomized 756 patients with gestational hypertension or mild preeclampsia to undergo either induction of labor or expectant monitoring. Women were between 36 and 41 weeks' gestation.

The investigators found that maternal outcomes were improved with the induction of labor. A poor maternal outcome was observed in significantly fewer patients randomized to induction of labor compared with expectant monitoring (31% vs. 44%). There was no significant difference in the number of cesarean sections performed in each group, and adverse neonatal outcomes did not differ.

Koopmans CM, Bijlenga D, Groen H, et al. Induction of labour versus expectant monitoring for gestational hypertension or mild pre-eclampsia after 36 weeks' gestation (HYPITAT): a multicentre, open-label randomised controlled trial. Lancet. 2009; Early Online Publication, 4 August 2009. doi:10.1016/S0140-6736(09)60736-4.

Related Videos
Why doxycycline PEP lacks clinical data for STI prevention in women
The importance of nipocalimab’s FTD against FNAIT | Image Credit:
Enhancing cervical cancer management with dual stain | Image Credit:
Fertility treatment challenges for Muslim women during fasting holidays | Image Credit:
Understanding the impact of STIs on young adults | Image Credit:
CDC estimates of maternal mortality found overestimated | Image Credit:
Study unveils maternal mortality tracking trends | Image Credit:
How Harmonia Healthcare is revolutionizing hyperemesis gravidarum care | Image Credit:
Unveiling gender disparities in medicine | Image Credit:
Exploring the intersection of heart health and women's health | Image Credit:
Related Content
© 2024 MJH Life Sciences

All rights reserved.